Noveris Health Sciences is trading at CA$0.07, down 6.25%, with no new company-specific announcement identified for September 28, 2026. - The latest located company release, dated September 9, covered annual meeting results, shareholder votes and director elections—not a new operating catalyst. - The broader market is described as risk-off amid higher yields and renewed oil-price pressure after the Iranian proposal was rejected, but no evidence establishes this as the direct cause of the decline.